Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Krüll (Berlin, Germany), R. Van Zyl-Smit (Cape town, South Africa), C. Gessner (Leipzig, Germany), Y. Gon (Tokyo, Japan), O. Noga (Berlin, Germany), A. Richard (Basel, Switzerland), A. De Los Reyes (New Jersey, United States of America), X. Shu (New Jersey, United States of America), A. Pethe (New Jersey, United States of America), A. Tanase (Basel, Switzerland), P. D'Andrea (New Jersey, United States of America). Effect of indacaterol/mometasone on lung function in adolescents versus overall patient population: PALLADIUM study. 2283

Member's Comments

No comment yet.

Related content which might interest you: Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study. Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Changes in performance status in continued smokers vs quitters after a diagnosis of lung cancer: a cohort study Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence Year: 2020 The effect of occupational farming on lung function development in young adults: A 15 year follow-up study Source: International Congress 2015 – Occupational factors in COPD and bronchitis Year: 2015 Effects of lifetime smoking patterns on nutrition, muscular and lung function in early COPD patients from the PAC-COPD cohort study Source: Eur Respir J 2007; 30: Suppl. 51, 283s Year: 2007 Indacaterol/glycopyrronium (IND/GLY) improves lung function, health status and rescue medication use vs salmeterol/fluticasone (SFC) independent of symptom response: The FLAME study Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 COPD characteristics and progression of patients with high vs low health status: an analysis of the observational DACCORD study Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Prevalence of asthmatic smokers: Turkish experience (PASTE study) Source: Annual Congress 2008 - Tobacco smoking by population subgroups Year: 2008 Regular physical activity and lung function decline. A population based cohort study Source: Eur Respir J 2006; 28: Suppl. 50, 294s Year: 2006 ACTIVATE: effect of aclidinium/formoterol on physical activity in patients with COPD Source: International Congress 2017 – COPD management Year: 2017 Quantifying comorbidity in individuals with COPD: a population study Source: Eur Respir J 2015; 45: 51-59 Year: 2015 The prevalence of restrictive lung function in a general population obtained by spirometry and bodyplethysmography-Data from the LEAD study Source: International Congress 2019 – Airway physiology Year: 2019 Predictors of lung function decline: a retrospective study in COPD patients Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Aero-allergen sensitization in a general population: data from the LEAD population cohort study Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Gender differences in health status in patients with COPD: baseline characteristics of a multi-centre intervention and characterisation study on Seretide (COSMIC) Source: Eur Respir J 2002; 20: Suppl. 38, 262s Year: 2002 Effects of BMI changes on lung function in COPD subjects from two longitudinal general population studies Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Breastfeeding is associated with increased lung function at 18 years of age: a cohort study Source: Eur Respir J 2012; 39: 985-991 Year: 2012 Effect of not appropriate treatment in severe/not controlled asthma: The AGAVE study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015